Lyrica News and Research

RSS
Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

FDA grants approval for generic versions of Lyrica

FDA grants approval for generic versions of Lyrica

Some clinical trials may promote use of ineffective and costly treatments, researchers say

Some clinical trials may promote use of ineffective and costly treatments, researchers say

Researchers develop electroencephalography-based test to objectively measure pain

Researchers develop electroencephalography-based test to objectively measure pain

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

Price check on drug ads: Would revealing costs help patients control spending?

Price check on drug ads: Would revealing costs help patients control spending?

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

New molecule-building method may have great impact on pharmaceutical industry

New molecule-building method may have great impact on pharmaceutical industry

American Pain Society releases new post-surgical pain management guideline

American Pain Society releases new post-surgical pain management guideline

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

Forest Laboratories enters into definitive agreement to acquire Furiex

Forest Laboratories enters into definitive agreement to acquire Furiex

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

FDA-approved drug pregabalin effectively treats RLS symptoms with less side effects

FDA-approved drug pregabalin effectively treats RLS symptoms with less side effects

Study suggests role for brain imaging in potential treatment of chronic pain

Study suggests role for brain imaging in potential treatment of chronic pain

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

Scientists create new compounds that could slow progression of Parkinson's

Scientists create new compounds that could slow progression of Parkinson's

Pfizer’s Lyrica does not affect reproductive function in healthy males

Pfizer’s Lyrica does not affect reproductive function in healthy males